Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands.
Autoimmun Rev. 2010 May;9(7):483-7. doi: 10.1016/j.autrev.2010.02.006. Epub 2010 Feb 13.
Wegener's Granulomatosis (WG) is an autoimmune disease with manifestations in different organ systems. The hallmark of WG is a necrotizing granulomatous inflammation of the upper and/or lower respiratory tract and systemic small vessel vasculitis which can involve multiple organ systems. The treatment of WG has evolved over the last decades. Steroid, cytotoxic and biologic therapies have been used leading to great improvements in outcome. However, still mortality is high and relapses are a major cause of mortality and morbidity. Despite intensified maintenance regimens and new possibilities of biologic therapies in WG the relapse rate is high. Even patients treated with high dose cytotoxic therapies in autologous stem cell treatment protocols have shown relapses in the course of disease. Increasing knowledge of the pathophysiology of granuloma in WG and new biologic therapies might be of great importance for future treatment of WG.
韦格纳氏肉芽肿(WG)是一种自身免疫性疾病,可在不同的器官系统中表现出来。WG 的特征是上呼吸道和/或下呼吸道的坏死性肉芽肿性炎症和全身性小血管血管炎,可累及多个器官系统。WG 的治疗在过去几十年中已经发展。已经使用了类固醇、细胞毒性和生物疗法,从而使预后得到了很大的改善。然而,死亡率仍然很高,复发是死亡率和发病率的主要原因。尽管强化了维持治疗方案,并在 WG 中采用了新的生物疗法的可能性,但复发率仍然很高。即使在自体干细胞治疗方案中接受高剂量细胞毒性治疗的患者,在疾病过程中也显示出复发。对 WG 中肉芽肿的病理生理学的深入了解和新的生物疗法可能对 WG 的未来治疗具有重要意义。